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Objective: The effect of eyedrops for glaucoma on conjunctival bacterial flora was investigated 
by comparing a group of patients treated with such eyedrops for at least 1 year to a control 
group that did not use eyedrops.
Methods: In both groups, bacterial culture came from scrapings of the conjunctival sac, and the 
bacterial infection rate and pattern of drug resistance were determined. Findings were analyzed 
in various subgroups stratified by age, frequency of instillation, and concentration of antiseptic 
benzalkonium chloride in the eyedrops.
Results: The culture-positive rate was significantly lower in the glaucoma eyedrop group 
(43/119 eyes, 40.3%) than in the control group (19/28 eyes, 67.8%) (P , 0.05). No differences 
in infection rate were found among the different age groups. The most frequent bacteria in both 
groups was coagulase-negative staphylococci. Gram-negative bacteria were only detected in the 
glaucoma eyedrop group. Retrospective evaluation was possible for 86 eyes of patients from 
the glaucoma eyedrop group, among which 45 eyes (52.3%) showed some corneal epithelium 
damage. There was no difference in the culture-positive rate of bacteria between patients who 
used eyedrops containing 0.01% or higher dose of benzalkonium chloride and those containing 
less than 0.01%. Strains that showed resistance to levofloxacin were significantly less frequent 
in the glaucoma eyedrop group (six strains, 15.0%) than in the control group (11 strains, 39.3%) 
(P , 0.05).
Conclusion: Patients using eyedrops for glaucoma had a lower culture-positive rate of bacteria 
in the conjunctival sac, probably due to being washed out by the eyedrops. However, Gram-
negative bacteria were detected in the eyedrop group. Bacteria isolated from the eyedrop group 
had lower resistance to levofloxacin, a finding that may have clinical relevance.
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Introduction
Instilling eyedrops may have various effects on the ocular surface. Patients with 
glaucoma need to instill eyedrops several times a day for a long period, which may 
have a marked effect on their eyes. Some eyedrops for glaucoma contain antiseptics 
at a higher concentration than that of the active ingredient, and previous reports have 
suggested that these antiseptics can damage the ocular surface.1,2 Eyedrops typically 
contain an active ingredient in a vehicle and an antiseptic. In most eyedrops, 
benzalkonium chloride (a cationic soap) is used as the antiseptic.1–4
In the present study, the effect of chronic use of eyedrops on conjunctival bacterial 
flora in patients who had instilled eyedrops to treat glaucoma for 1 year or more was 
investigated. After isolating bacteria from the conjunctival sac in these patients, the Infection and Drug Resistance 2011:4 submit your manuscript | www.dovepress.com
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bacterial infection rate and pattern of drug resistance were 
compared with those in a control group.
Materials and methods
Patients
The subjects were 119 patients with primary open angle 
glaucoma who had used eyedrops for 1 year or more and 
who attended the glaucoma outpatient department of 
Juntendo University Hospital during 6 months from April 
to September 2004. Declaration of Helsinki and written 
consent was provided by all patients. Subjects consented to 
a scraping specimen from one eye being sent for bacterial 
culture and typing. The patients in the glaucoma eyedrop 
group were treated with mono or combined topical therapies 
(prostaglandin analogs, carbonic anhydrase inhibitors, 
β-blockers, α2 agonists, and nonselective sympathetic and 
parasympathetic stimulants) (Table 1). Exclusion criteria 
included subjects with suspected inflammation of the anterior 
eye, subjects administered with antibiotic medicine orally, 
and subjects using eyedrops that were not for glaucoma, 
such as antibiotics or artificial tears. Further, patients with 
diabetes mellitus and patients treated with corticosteroids 
were also excluded because of easy infections and a higher 
number of positive conjunctival cultures.5 The control 
group consisted of 28 subjects who visited these hospitals 
during the same period, did not have glaucoma or untreated 
cataract, and who did not use eyedrops. Exclusion criteria 
were the same as described above. In the glaucoma eyedrop 
group, conjunctival scrapings were taken from the treated 
eyes, while scrapings were obtained from the right eye in 
the control group.
Investigations
Isolated bacteria were cultured and drug sensitivity tested 
using the disk diffusion method (Kirby–Bauer method) based 
on previous studies.6,7 The samples taken for culture from 
Table 1 Details of antiglaucoma eyedrops and number of enrolled eyes
Antiglaucoma drugs Instillation  
frequency/day
BAC concentration Enrolled eyes (N)
Prostaglandin analogs
Latanoprost 0.005%  
(Xalatan®, Pfizer Inc, New York, NY)
1 0.02% 44
Unoprostone isopropyl 0.12%  
(Rescula®, Santen Pharmaceutical Co, Ltd, Osaka, Japan)
2 0.01% 23
Carbonic anhydrase inhibitors
Dorzolamide hydrochloride 1%  
(Trusopt®, Merck sharp and Dohme corp,  
Whitehouse Station, NJ)
3 0.005% 23
Brinzolamide 1%  
(Azopt®, Alcon Laboratories, Inc, Fort Worth, TX)
2 0.01% 1
β-blockers
Levobunolol hydrochloride 0.5%  
(Mirol®, Kaken Pharmaceutical Co, Ltd, Tokyo, Japan)
2 0.004% 20
Timolol maleate 0.5%  
(Timoptol®, Santen Pharmaceutical Co, Ltd, Osaka, Japan)
2 0.005% 18
carteolol hydrochloride 2%  
(Mikelan®, Otsuka Pharmaceutical Co, Ltd, Tokyo, Japan)
2 0.005% 16
nipradilol 0.25%  
(Hypadil®, Kowa Company Ltd, Tokyo, Japan)
2 0.01% 5
Betaxolol hydrochloride 0.5%  
(Betoptic®, Alcon Laboratories)
2 0.01% 5
α1-blockers
Bunazosin hydrochloride 0.01%  
(Detantol®, Santen Pharmaceutical)
2 0.05% 16
Parasympathetic stimulant
Pilocarpine hydrochloride 1% or 2%  
(sanpilo®, Santen Pharmaceutical)
3 0% 2
Sympathetic stimulant
Dipivefrin hydrochloride 0.1%  
(Pivalephrine®, Santen Pharmaceutical)
2 0.05% 2
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the patients with bacterial keratitis were collected by one 
ophthalmologist (RH) using a sterile cotton swab with topi-
cal anesthesia from the lower conjunctival sac. The collected 
materials were routinely smeared onto slides and stained with 
Gram staining and streaked over the surface of blood agar, 
chocolate agar, and Sabouraud agar for culture. Cultures were 
positive if organisms were grown along the line of inocula-
tion on the agar plates. The bacteria were identified using 
standard laboratory techniques. Antibiotic susceptibilities 
were recorded following the National Committee for Clinical 
Laboratory Standards method.8,9
The bacterial culture-positive rate, species of bacteria, 
and drug sensitivity were recorded. Subgroup analysis 
assessed the bacterial culture-positive rate in relation to 
the frequency of instillation, number of different eyedrops 
used, and the concentration of antiseptics contained in each 
eyedrop. According to the frequency of instillation, patients 
were classified into three groups: the control group, a group 
using eyedrops one to two times a day, and a group using 
eyedrops three or more times a day. Based on the number 
of types of eyedrops used, patients were also classified 
into three groups: the control group, a group using one 
type of eyedrop, and a group using two or more types of 
eyedrops.
Statistical analyses were performed using SPSS for 
  Windows (v 14.0; SPSS Inc, Chicago, IL). The 2 × 2 Chi 
square test was employed for categorical comparison. 
Comparisons of the continuous variables between and within 
groups were performed by Mann–Whitney U tests.
Results
The glaucoma eyedrop group contained 119 subjects (52 men 
and 67 women) with a mean age of 64.3 ± 13.4 years (range 
28–88 years). The control group consisted of 28 subjects 
(13 men and 15 women) with a mean age of 64.5 ± 17.4 
years (range 30–83 years) (Table 2). Details of antiglaucoma 
eyedrops of enrolled patients are shown in Table 1.
Table 3 Bacterial isolates from the glaucoma eyedrop and control 
groups
Glaucoma  
eyedrop
Control
Gram-positive bacteria 
coagulase-negative staphylococci 
Corynebacterium spp. 
Propionibacterium acnes 
group B Streptococcus 
Staphylococcus aureus 
Finegoldia magna
52 (91.3%) 
33 (57.9%) 
11 (19.3%) 
4 (7.0%) 
3 (5.3%) 
1 (1.8%)
28 (100%) 
14 (50.0%) 
7 (25.0%) 
 
6 (21.4%) 
6 (21.4%)*
1 (3.6%)
Gram-negative bacteria 
Haemophilus influenzae 
Serratia marcescens 
Enterobacter spp. 
Stenotrophomonas maltophilia
5 (8.9%) 
2 (3.5%) 
1 (1.8%) 
1 (1.8%) 
1 (1.8%)
0 (0%)
Note: *P < 0.05.
Table 2 The culture-positive rate in glaucoma eyedrop and control 
groups
Group Total number  
of eyes
Culture- 
positive rate
%
Glaucoma eyedrop 119 48 40.3*
Male 52 25 48.1
Female 67 23 34.3
Control 28 19 67.8
Male 13 9 69.2
Female 15 10 66.6
Notes: The bacterial culture-positive rate in the glaucoma eyedrop group was 
significantly lower than in the control group. *P , 0.05, 2 × 2 chi square test.
The bacterial culture-positive rate was 40.3% (48/119 
eyes) in the glaucoma eye group and 67.8% (19/28 eyes) in the 
control group, being significantly lower in the eyedrop group 
(P , 0.05) (Table 2). There was no significant difference 
in the culture-positive rate between men and women from 
the eyedrop group (48.1% [25/52 eyes] for men and 34.3% 
[23/67 eyes] for women). In the control group, there was also 
no significant difference of the bacterial culture-positive rate 
between the genders (69.2% [9/13 eyes] for men and 66.6% 
[10/15 eyes] for women). The culture-positive rate was lower 
in the glaucoma eyedrop group than in the control group 
for all age groups, but there were no significant differences 
between any two age groups.
In the glaucoma eyedrop group, ten bacterial species 
(57 strains) were detected from 48 eyes and 52 of these 
strains (91.3%) were Gram-positive bacteria (Table 3). 
Coagulase-negative staphylococci such as Staphylococcus 
epidermidis (33 strains, 57.9%) were the most frequently 
observed bacteria, followed by Corynebacterium diphtheriae 
(11 strains, 19.3%), Propionibacterium acnes (four strains, 
7.0%), Group B Streptococcus (three strains, 5.3%), and 
methicillin-sensitive Staphylococcus aureus (one strain, 
1.8%). Gram-negative bacteria included Haemophilus 
influenzae (two strains, 3.5%), Serratia marcescens (one 
strain, 1.8%), Enterobacter spp. (one strain, 1.8%), and 
Stenotrophomonas maltophilia (one strain, 1.8%).
In the control group, four bacterial species (28 strains) 
were identified from 19 eyes. All of these were Gram-positive, 
including coagulase-negative staphylococci (14 strains, 
50.0%), C. diphtheriae (seven strains, 25.0%), Group B 
streptococcus (six strains, 21.4%), methicillin-sensitive S. 
aureus (six strains, 21.4%), and Finegoldia magna (one strain, 
3.6%) (Table 3). The two most frequently detected bacteria Infection and Drug Resistance 2011:4 submit your manuscript | www.dovepress.com
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were the same as in the glaucoma eyedrop group. The results 
were similar to those obtained in a study conducted at the 
authors’ institution in 1998 where conjunctival sac bacteria 
were isolated from patients who were not using eyedrops 
while awaiting cataract surgery (unpublished data). In the 
present study, the isolation rate of S. aureus was significantly 
higher in the control group (21.4%) than in the glaucoma 
eyedrop group (1.8%; P < 0.05), but methicillin-resistant S. 
aureus was not identified in either group.
The culture-positive rate was significantly lower in the 
glaucoma eyedrop group than in the control group (P , 0.01). 
There were no significant differences in the culture-positive 
rate among subgroups of subjects stratified by frequency of 
instillation per day (Table 4), nor stratified by the number of 
eyedrop medications (Table 5).
Furthermore, in the glaucoma eyedrop group, comparison 
of the patients using eyedrops containing $0.01% 
benzalkonium chloride (latanoprost, nipradilol, unoprostone, 
betaxolol hydrochloride) with those using eyedrops 
containing ,0.01% benzalkonium chloride revealed that 
there was no significant difference in the bacterial culture-
positive rate (data not shown). When the total daily dose of 
benzalkonium chloride was calculated by multiplying the 
concentration in each eyedrop preparation by the frequency 
and volume of dosing, there were no significant differences 
among subgroups stratified by total dose. Damage to the 
corneal epithelium is an ophthalmologic disorder that may 
be associated with benzalkonium chloride. Such damage 
was observed in 45/86 eyes (52.3%) of the 86 subjects who 
could be retrospectively evaluated, including superficial 
punctate keratopathy (Figure 1) in 43 eyes (50.0%) and 
corneal epithelial erosions in two eyes (2.3%).
The percentage of strains for which drug sensitivity 
was determined was similar in both groups (40/57 strains 
[70.2%] in the glaucoma eyedrop group and 19/28 strains 
[67.9%] in the control group). Resistance to levofloxacin 
was significantly lower in the glaucoma eyedrop group 
(6/40 strains, 15.0%) than in the control group (11/19 strains, 
57.9%) (P , 0.05).
Discussion
It has been suggested that instillation of eyedrops can 
decrease the culture-positive rate of bacteria. The present 
study of subjects treated with glaucoma eyedrops for 1 year 
or more yielded findings consistent with this, since fewer 
bacteria were detected in the subjects using eyedrops. In 
a previous study, the conjunctival culture-positive rate 
was higher in patients with glaucoma than in the healthy 
  controls.10 However, there are some differences between 
these studies which should be noted. The follow-up period 
was twice as long in the present study than the previous study. 
Also, patients with diabetes mellitus and patients treated with 
corticosteroids were excluded in the present study.
Comparisons between subgroups stratified by the number 
of drugs or the concentration of benzalkonium chloride in 
the eyedrops showed no statistically significant differences 
Table  4  Frequency  of  instillation  per  day  and  bacterial 
detection rate
Frequency of  
instillation/day
Total number  
of eyes
Culture-positive  
rate
%
0 19 28 67.8
1 3 9 33.3
2 16 40 40.0
3 8 19 42.1
4 5 21 23.8
5 4 8 50.0
6 4 15 26.7
7 1 3 33.3
8 1 3 33.3
9 0 1 0
Note: There were no significant differences.
Figure 1 corneal epithelial damage associated with glaucoma eyedrops. The right 
eye was stained by fluorescein solution for ophthalmological diagnosis. A 51-year-
old man had glaucoma in both eyes and was treated by unoprostone isopropyl 0.12% 
which included 0.01% benzalkonium chloride. It was shown in both eyes and treated 
with hyaluronic acid eyedrops without benzalkonium chloride.
Table  5  The  number  of  antiglaucoma  eyedrops  per  day  and 
bacterial detection rate
Number of  
eyedrops
Total number  
of eyes
Culture-positive  
rate
%
1 19 49 38.8
2 27 39 69.2
3 17 27 63.0
4 1 4 25.0
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in the bacterial culture-positive rate. These findings suggest 
that eyedrops achieve a disinfectant or sterilizing effect even 
when only one type is used or when eyedrops that have a low 
antiseptic content are employed, and this effect is not much 
enhanced when the number of types of eyedrops is increased. 
Before performing this study, it was expected that subjects 
who frequently instilled eyedrops might have lower bacterial 
culture-positive rates due to a washout effect. However, it was 
found that the frequency of instillation does not affect the 
culture-positive rate, suggesting that the sterilizing effect of 
antiseptic in eyedrops was more important.
Since glaucoma patients are usually treated with eyedrops 
for a long period, the effect of antiseptics in these drops 
on the conjunctival bacterial flora should be evaluated 
carefully.1–4,10 An important finding of the present study was 
the detection of Gram-negative bacteria in the glaucoma 
eyedrop group. This suggests that antiseptics affect the 
bacterial flora residing on the ocular surface, perhaps by 
microbial substitution. On the other hand, it is intriguing 
that resistance to levofloxacin was significantly lower in 
the glaucoma eyedrop group than in the control group. This 
may make sense in theory because benzalkonium chloride 
is an antiseptic rather than an antimicrobial agent, therefore 
the bacteria should not acquire resistance. However, it is not 
known why the rate of levofloxacin resistance was lower in 
the glaucoma eyedrop group. Bacterial drug resistance poses 
an increasing problem in clinical practice. Antiseptics such 
as benzalkonium chloride, which has a sterilizing effect and 
appears to reduce drug resistance, may have some advantages 
in the clinical setting.
The bactericidal effect of benzalkonium chloride depends 
on the positively-charged drug adsorbing and causing the 
degeneration of negatively-charged bacteria. Benzalkonium 
chloride has a bactericidal effect on most bacteria, except 
for tuberculosis and spore-forming bacteria. It has no effect 
on viruses and fungi, which are not negatively-charged, as 
well as no effect on Pseudomonas aeruginosa and some 
methicillin-resistant S. aureus. Benzalkonium chloride is thus 
an antiseptic with limited efficacy, so caution should be used 
when estimating its influence as an antiseptic in eyedrops. 
There have been several reports about bacterial contamination 
in the bottle of eyedrops that occurred after prolonged use,11,12 
although this was not a concern in the present study.
Hori et al reported that the bacterial culture-positive 
rate was the same in healthy subjects and in patients with 
dry eyes who were using artificial tears that did not contain 
antiseptics, but resistance to levofloxacin was higher in the 
patients.13 It has not been determined whether this is due to 
changes of the ocular surface in the patients with dry eyes or 
is caused by bacterial contamination from the fingers or eye-
lids of patients using eyedrops.11,12 The present study yielded 
the contrary result that chronic instillation of eyedrops for 
glaucoma containing an antiseptic led to lower resistance to 
levofloxacin.
To avoid conjunctival and corneal damage, a benzalkonium 
chloride concentration of 0.01%–0.05% is recommended, 
although the concentration in most eyedrops is below this 
recommended range.14 However, corneal epithelial damage 
that was probably caused by benzalkonium chloride was 
observed in about half of subjects as a complication of 
eyedrop therapy. Particular attention should be paid to this 
finding with regard to the sensitivity of the ocular surface.
It is known that the culture-positive rate of ocular bacteria 
increases with age. Age-related changes include a decrease of 
resistance and immune function, decreased lacrimation, and 
impaired self-cleansing of the ocular surface due to narrowing 
of the nasolacrimal duct. However, no differences in the 
bacterial culture-positive rate among different age groups in 
the glaucoma eyedrop group were found. Thus, washing out 
of bacteria after instillation of eyedrops may compensate for 
impaired self-cleansing of the ocular surface.
The present study investigated the effect of benzalkonium 
chloride as an antiseptic in glaucoma eyedrops. Future 
studies should investigate the effects and side effects of 
active ingredients, and the effects on conjunctival bacterial 
flora of other vehicles, antiseptics, activating agents, and 
their combinations. Furthermore, newer drug combinations 
requiring less instillation frequency are being increasingly 
used, and any changes associated with these new formulations 
should be monitored. In particular, less instillation frequency 
caused by fixed combinations of antiglaucoma eyedrops 
will offer the potential of maximizing patient adherence by 
decreasing the burden of using multiple topical agents.15,16 The 
incidence of ocular surface disorder caused by antiglaucoma 
eyedrops may also decrease. The present study may be one 
of the last performed in the era when common eyedrops for 
glaucoma contain only one active ingredient.
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